Abstract Submission is Now Closed
Submission Close Date: October 27, 2023
No fee for non-industry-sponsored abstracts;
$495 per abstract for industry-sponsored abstracts.
We invite all registered meeting attendees to submit abstracts for poster presentation on their latest research in cardiology including heart failure & myocardial disease, rhythm disorders, CV risk reduction, cardiometabolic updates, and arterial & venous disease. A list of abstracts will be selected as oral presentations and/or poster display during the conference.
At least one (1) author must be registered for the in-person meeting to have their abstracts considered for oral presentation and/or poster display. All submissions accepted for oral presentation must also create and provide a poster for display.
Get Read By QxMD
The platform drives awareness, dissemination and engagement with this content via the Read by QxMD platform, as an educational tactic to drive CQI. ‘Read’ works on iPhone, iPad, Android smartphones & tablets and any web-enabled device (including desktops), and uses channels such as mobile, email and push notification to connect with our global community of healthcare providers and researchers.
Formatting and Content Guidelines
Full Last Name, First Name, Affiliations, Degrees and Contact Information
Please include full contact information of corresponding author
(Verify that your email address is accurate, to ensure receipt of correspondence)
Maximum of 3000 characters, including spaces
(not including the title, authors, or affiliations)
A "structured abstract" format is preferred
Sections marked as: Background, Objectives, Methods, Results, and Conclusions
Reference must be included as parenthetical in-text citations first author, et al, journal and year
ex. (Cruz D, et al. Blood 2012)
Figures and Table Count
Maximum of 2 relevant tables or figures
Submit images as attachments and reference figure or table as an in-text citation
(do not embed in the Word Document file)
Image File Format
Image File Resolution
Note: Abstracts containing non-generic drug names or personal patient information, or reporting studies with unidentified chemical compounds, drugs, or materials, will not be accepted.